홈
마켓
차트 & 아이디어
Algo
뉴스
스토어
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
히트맵
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
L
LABU
Direxion Daily S&P Biotech Bull 3X Shares
1.9
5
USD
+1.90%
부문:
금융
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.90%
월간 변동
-98.86%
6달 변화
-98.79%
년간 변동율
-98.41%
이전 종가
1.9
2
Open
1.9
4
저가
1.9
3
High
1.9
6
양
124
마켓
US ETFs
LABU
전체 차트 열기
Full chart
개요
모든 보유 자산
히트맵
주요 보유 종목
Market Value
Shares
Weight %
NBIX
Neurocrine Biosciences Inc
3.4 M
24.8 K
0.6%
CRSP
CRISPR Therapeutics AG
3.3 M
67.0 K
0.6%
ADMA
Adma Biologics Inc
3.3 M
193.2 K
0.6%
ACAD
Acadia Pharmaceuticals Inc
3.3 M
131.5 K
0.6%
BEAM
Beam Therapeutics Inc.
3.2 M
117.3 K
0.6%
ALNY
Alnylam Pharmaceuticals Inc.
3.2 M
9 543.0
0.6%
INSM
Insmed Inc
3.2 M
20.3 K
0.6%
A
ACLX
Arcellx Inc
3.2 M
46.1 K
0.5%
NUVL
Nuvalent Inc
3.1 M
30.5 K
0.5%
TWST
Twist Bioscience Corporation
3.1 M
75.8 K
0.5%
VKTX
Viking Therapeutics Inc.
3.0 M
102.8 K
0.5%
ARQT
Arcutis Biotherapeutics Inc.
2.9 M
114.1 K
0.5%
KYMR
Kymera Therapeutics Inc
2.8 M
38.9 K
0.5%
DYN
Dyne Therapeutics Inc.
2.8 M
155.1 K
0.5%
SMMT
Summit Therapeutics Inc.
2.8 M
190.9 K
0.5%
DNLI
Denali Therapeutics Inc
2.8 M
127.1 K
0.5%
IDYA
IDEAYA Biosciences Inc.
2.7 M
83.8 K
0.5%
RXRX
Recursion Pharmaceuticals Inc
2.7 M
642.7 K
0.5%
COGT
Cogent Biosciences Inc.
2.6 M
73.7 K
0.5%
SRPT
Sarepta Therapeutics Inc
2.6 M
129.5 K
0.5%
1
2
3
4
5
6
7
8
뉴스
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil
CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies
Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors